The purpose of this paper was to evaluate the stability of vorinostat, vorinostat O-glucuronide (M1) and 4-anilino-4-oxobutanoic acid (M2) in plasma, serum and urine specimens.
Stability studies of vorinostat and its two metabolites in human plasma, serum and urine.
Du L, Musson DG, Wang AQ
Purpose
Conclusion
Storage of heparinized plasma at -70 degrees C for up to 5 weeks, serum for up to 57 weeks, or urine specimens for up to 58 weeks did not affect vorinostat or its metabolites. In neutral or acidified EDTA plasma, vorinostat declined by about 10% during the first week of storage at -70 degrees C but then stabilized. M1 was found to be more stable with storage in neutral plasma than acidified plasma, and M2 was relatively stable in both. Up to 3 freeze-thaw cycles had no effect on vorinostat, M1 or M2 levels in EDTA plasma, serum, or urine specimens. However, in heparinized plasma specimens, 3 freeze-thaw cycles led to an approximately 10% reduction in vorinostat levels. Storage of blood specimens for up to 180 minutes prior to centrifugation did not result in significant changes in serum concentrations of vorinostat, M1 or M2.
Studies (1)
Purpose
The purpose of this study was to determine the effects of storage and freeze-thaw cycling on vorinostat, M1 and M2 in neutral and acidified EDTA plasma, heparin plasma, serum and urine specimens. For all specimens vorinostat, M1 and M2 were added to the specimen prior to storage.
Summary of Findings
Storage of heparinized plasma at -70 degrees C for up to 5 weeks, serum for up to 57 weeks, or urine specimens for up to 58 weeks did not affect vorinostat or its metabolites. In neutral or acidified EDTA plasma, vorinostat declined by about 10% during the first week of storage at -70 degrees C but then stabilized. M1 was found to be more stable with storage in neutral plasma than acidified plasma, and M2 was relatively stable in both. Acidification of plasma specimens with formic acid led to decreased precision of the M1 and M2 assays, and acidification with high concentrations of acetic acid led to reduced precision and accuracy of M1 and M2 at low concentrations. Up to 3 freeze-thaw cycles had no effect on vorinostat, M1 or M2 levels in EDTA plasma, serum, or urine specimens. However, in heparinized plasma specimens, 3 freeze-thaw cycles led to an approximately 10% reduction in vorinostat levels. Little conversion between vorinostat, M1 and M2 in EDTA plasma specimens was observed. Storage of blood specimens for up to 180 minutes at room temperature prior to centrifugation did not result in significant changes in serum concentrations of vorinostat, M1 or M2.
Biospecimens
FluidPlasmaFluidSerumFluidUrineFluidBloodPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
Small moleculeLC-MS or LC-MS/MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant EDTAHeparinBiospecimen Acquisition Biospecimen location PlasmaSerumUrineBiospecimen Aliquots and Components pH 4.77Storage Freeze/thaw cycling 0 cycles3 cyclesStorage Storage duration 0 weeks1 week10 weeks2 weeks5 weeks57 weeks58 weeks7 weeks9 weeksStorage Storage temperature -70 degrees CStorage Time at room temperature 120 min15 min180 min30 min60 min